These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2146503)

  • 1. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.
    Heijboer H; Brandjes DP; Büller HR; Sturk A; ten Cate JW
    N Engl J Med; 1990 Nov; 323(22):1512-6. PubMed ID: 2146503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent venous thrombosis and hypercoagulable states.
    Bolan CD; Alving BM
    Am Fam Physician; 1991 Nov; 44(5):1741-51. PubMed ID: 1835274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital abnormalities related to coagulation and the fibrinolytic system in patients with vein thrombosis of the lower extremities].
    Murayama H; Manabe S; Matsuda M
    Nihon Geka Gakkai Zasshi; 1986 Apr; 87(4):450-5. PubMed ID: 3754931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J; Veuillet-Duval A; Horellou MH; Samama M
    Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of dysplasminogenemia in occurrence of deep vein thrombosis.
    Kawasaki T; Kambayashi J; Uemura Y; Sakon M; Shiba E; Suehisa E; Amino N; Mori T
    Int Angiol; 1995 Mar; 14(1):65-8. PubMed ID: 7658107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis.
    Gladson CL; Scharrer I; Hach V; Beck KH; Griffin JH
    Thromb Haemost; 1988 Feb; 59(1):18-22. PubMed ID: 2966450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.
    den Heijer M; Koster T; Blom HJ; Bos GM; Briet E; Reitsma PH; Vandenbroucke JP; Rosendaal FR
    N Engl J Med; 1996 Mar; 334(12):759-62. PubMed ID: 8592549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
    Finazzi G; Barbui T
    Thromb Haemost; 1994 Jan; 71(1):15-8. PubMed ID: 8165635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study).
    Mateo J; Oliver A; Borrell M; Sala N; Fontcuberta J
    Thromb Haemost; 1997 Mar; 77(3):444-51. PubMed ID: 9065991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory identification of conditions predisposing to thrombosis.
    Sanfelippo MJ; Caya JG
    Wis Med J; 1990 Nov; 89(11):635-8. PubMed ID: 2148045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis.
    Tabernero MD; Tomas JF; Alberca I; Orfao A; Lopez Borrasca A; Vicente V
    Am J Hematol; 1991 Apr; 36(4):249-54. PubMed ID: 1826407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.
    Bertram B; Remky A; Arend O; Wolf S; Reim M
    Ger J Ophthalmol; 1995 Nov; 4(6):332-5. PubMed ID: 8751097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
    Eid SS
    Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and acquired inhibitors of hemostasis in selected symptomatic outpatients with venous thromboembolic disease.
    Bazzan M; Tamponi G; Vaccarino A; Montaruli B; Aluffi E; Schinco P; Pannocchia A; Borchiellini A; Rabbia C; Pileri A
    Haematologica; 1997; 82(4):420-2. PubMed ID: 9299854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
    Sie P
    Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
    [No Abstract]   [Full Text] [Related]  

  • 18. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The genetics of thrombosis].
    Girolami A; Simioni P; Zanardi S; Coser E; Signora S
    Haematologica; 1991 Jun; 76 Suppl 3():249-60. PubMed ID: 1836447
    [No Abstract]   [Full Text] [Related]  

  • 20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.